Knoze Jr. Corporation – Trademark Portfolio
Entity Type: 03
Knoze Jr. Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ALLERPOPS and ALLERKREAM. The owner is based in Los Alamos, NM.
635 Navajo Rd.
Los Alamos, NM 87544
Showing of trademarks Trademarks
Trademark Classifications
Knoze Jr. Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Knoze Jr. Corporation have?
Knoze Jr. Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Knoze Jr. Corporation file in?
Knoze Jr. Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Knoze Jr. Corporation's most well-known trademarks?
Knoze Jr. Corporation's registered trademark portfolio includes well-known marks such as ALLERPOPS and ALLERKREAM. These are among 2 currently registered trademarks in the portfolio.
What is Knoze Jr. Corporation's trademark registration success rate?
Knoze Jr. Corporation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.